Source:http://linkedlifedata.com/resource/pubmed/id/20601071
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2010-8-10
|
pubmed:abstractText |
Epoxyeicosatrienoic acids (EETs) induce vasorelaxation, probably through G protein-coupled receptors. The identity of these receptors is unclear, but it has been reported that EETs may bind to peroxisome proliferator activated receptors (PPARs) and E-prostanoid (EP) receptors. Therefore, we studied whether PPARs or EP receptors were involved in 14,15-EET-induced vasorelaxation. Isometric tensions of rat mesenteric arteries were measured. The vasorelaxant effect of 14,15-EET was inhibited by NF449 (G(s)-protein inhibitor), Rp-cAMP (cAMP antagonist) and KT5720 (PKA inhibitor), suggesting that the effect of 14,15-EET was mediated through G(s) protein-coupled receptors which were linked to the cAMP/PKA-dependent pathway. Pretreatments with MK886 (PPAR(alpha) antagonist) and GW9662 (PPAR(gamma) antagonist) did not influence 14,15-EET-induced vasorelaxation. The vasorelaxant effect of 14,15-EET was inhibited by AH6809 (EP(2) receptor antagonist), whereas SC19220 (EP(1) receptor antagonist), L798106 (EP(3) receptor antagonist) and GW627368X (EP(4) receptor antagonist) had no effect. The effect of 14,15-EET and the mechanism involved was mimicked by prostaglandin E(2) (an EP(2) receptor agonist). The 14,15-EET-induced relaxation was slightly potentiated in the presence of indomethacin (cyclooxygenase inhibitor which block PGE(2) synthesis). Binding study showed that the amount of 14,15-EET bound to the cell membrane of rat mesenteric arterial smooth muscle cells was much higher than that bound to the nuclear membrane. The binding of 14,15-EET to the cell membrane was attenuated by AH6809 and siRNA against EP(2) receptors. In conclusion, our study has demonstrated that 14,15-EET exerts relaxant effects on rat mesenteric arteries, at least partly via the stimulation of EP(2) receptors. This subsequently leads to activation of cAMP/PKA-dependent pathway in vascular smooth muscle cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/14,15-epoxy-5,8,11-eicosatrienoic...,
http://linkedlifedata.com/resource/pubmed/chemical/8,11,14-Eicosatrienoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, EP2...,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1098-8823
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Print
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
44-51
|
pubmed:meshHeading |
pubmed-meshheading:20601071-8,11,14-Eicosatrienoic Acid,
pubmed-meshheading:20601071-Animals,
pubmed-meshheading:20601071-Mesenteric Arteries,
pubmed-meshheading:20601071-Muscle, Smooth, Vascular,
pubmed-meshheading:20601071-Rats,
pubmed-meshheading:20601071-Rats, Sprague-Dawley,
pubmed-meshheading:20601071-Receptors, Prostaglandin E, EP2 Subtype,
pubmed-meshheading:20601071-Vasodilation,
pubmed-meshheading:20601071-Vasodilator Agents
|
pubmed:year |
2010
|
pubmed:articleTitle |
14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP(2) receptors in rat mesenteric artery.
|
pubmed:affiliation |
Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|